The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $22 million firm fixed price definitive contract to Pfizer Inc. for TRAUNCHE 2 PHARMACEUTICALS in support of the national response effort to the novel coronavirus COVID-19 pandemic. Pfizer will deliver pharmaceutical products to address the coronavirus from its facilities in New York through May 2021. No subcontractors or set aside designations were identified. This contract advances the HHS mission to prepare for and respond to public health emergencies through targeted procurement of medical countermeasures.
Generated 12/29/23, 3:46 PM